Defense Health Agency Contracting Activity - DHACA
DoW Multiple Sclerosis Clinical Trial Award
DoW Multiple Sclerosis Clinical Trial Award is a funding opportunity from Defense Health Agency Contracting Activity - DHACA, closing August 13, 2026.
Aug 13, 2026
(13d left)Overview
Summary: The fiscal year 2026 (FY26) Multiple Sclerosis Research Program (MSRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis. All applications must address at least one of the FY26…